Featured
Crossing the Final Frontier: First In-Vivo CRISPR Therapy Successfully Reverses Huntington’s Disease in Human Trial
The first in-vivo human trial of a novel lipid nanoparticle CRISPR therapy has successfully crossed the blood-brain barrier to treat Huntington's dise...
Read Full Story →